StatPearls, LLC

  • Felty Syndrome
  • Leukocyte Count
  • Methotrexate
  • Neutropenia
  • Reinfection

Felty Syndrome

Felty syndrome is a rare extra-articular manifestation of seropositive rheumatoid arthritis characterized by RA, neutropenia, and splenomegaly. While the etiology remains somewhat obscure, baseline data suggests an association with certain human leukocyte antigen (HLA) subtypes. The development of antibodies to granulocyte colony-stimulating factor (G-CSF) heralds the onset of neutropenia. Other autoantibodies may be evident. T-cell entities may also demonstrate this anomaly. Severe or recurrent infection is particularly concerning due to neutropenia, especially in the skin and respiratory system. Therapy is directed towards improving the white blood cell count and avoiding infections. This is performed, in large part, with steroids, methotrexate, and monoclonal antibody therapy. This activity focuses on increasing awareness about this rare condition and discussing the importance of interprofessional care in treating affected patients. Clinicians gain a deep understanding of the therapeutic landscape for Felty syndrome, focusing on treatment strategies and enhancing their ability to link dermatological presentations to systemic conditions. By fostering increased awareness, this activity aims to equip healthcare professionals with the knowledge and skills needed to diagnose and manage individuals with Felty syndrome effectively while optimizing patient outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 7 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left